WHO heads back to the drug development drawing board.

摘要

In 2009, WHO brought together 24 experts to assess schemes and innovative proposals that could encourage much-needed research and development into drugs for neglected diseases. The final report by the Expert Working Group (EWG) was due to be rubber-stamped at the 63rd World Health Assembly, held in Geneva, Switzerland, from May 17-21, 2010. Instead, frustration over what some perceived to be a missed opportunity, unclear methods, a lack of transparency, and signs of industry interference led to a week of protracted negotiations, culminating in the creation of a new Consultative EWG (CEWG).